— Know what they know.
Not Investment Advice

HROW NASDAQ

Harrow Health, Inc.
1W: +6.8% 1M: -15.8% 3M: -36.6% YTD: -34.0% 1Y: +17.4% 3Y: +56.6% 5Y: +267.0%
$33.00
+0.04 (+0.12%)
 
Weekly Expected Move ±12.7%
$23 $27 $31 $35 $39
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 34 · $1.2B mcap · 28M float · 3.04% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
58.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 9.6%  ·  5Y Avg: -2.3%
Cost Advantage
48
Intangibles
60
Switching Cost
63
Network Effect
72
Scale
47
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HROW has a Narrow competitive edge (58.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 9.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$88
Low
$88
Avg Target
$88
High
Based on 1 analyst since May 11, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$73.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-13 Cantor Fitzgerald Steve Seedhouse $94 $88 -6 +205.7% $28.79
2026-03-18 BTIG Thomas Shrader Initiated $63 +81.7% $34.68
2026-03-04 H.C. Wainwright Yi Chen $64 $70 +6 +76.7% $39.62
2025-11-11 Cantor Fitzgerald $76 $94 +18 +142.6% $38.74
2025-09-29 Lake Street Thomas Flaten $55 $70 +15 +48.6% $47.10
2025-09-23 Craig-Hallum Chase Knickerbocker $45 $64 +19 +30.8% $48.93
2025-08-13 H.C. Wainwright Yi Chen Initiated $64 +83.7% $34.83
2025-07-11 Cantor Fitzgerald Steve Seedhouse Initiated $76 +117.6% $34.93
2024-10-18 B.Riley Financial Sahil Kazmi Initiated $73 +29.4% $56.41
2024-10-04 Lake Street Brooks O'Neil $25 $55 +30 +10.6% $49.75
2024-08-09 Craig-Hallum Chase Knickerbocker $30 $45 +15 +27.7% $35.25
2024-06-21 Craig-Hallum Chase Knickerbocker Initiated $30 +50.5% $19.93
2024-06-03 Loop Capital Markets Brooks O'Neil Initiated $25 +41.4% $17.68
2024-06-03 Lake Street Brooks O'Neil Initiated $25 +37.9% $18.12

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HROW receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

45 Grade D
Profitability
18
Balance Sheet
34
Earnings Quality
42
Growth
88
Value
32
Momentum
80
Safety
65
Cash Flow
41
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HROW scores highest in Growth (88/100) and lowest in Profitability (18/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.91
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.84
Unlikely Manipulator
Ohlson O-Score
-4.32
Bankruptcy prob: 1.3%
Low Risk
Credit Rating
BB-
Score: 38.9/100
Trend: Improving
Earnings Quality
OCF/NI: -1.02x
Accruals: -7.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HROW scores 2.91, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HROW scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HROW's score of -2.84 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HROW's implied 1.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HROW receives an estimated rating of BB- (score: 38.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-82.12x
PEG
0.36x
P/S
4.58x
P/B
42.80x
P/FCF
91.85x
P/OCF
86.34x
EV/EBITDA
37.36x
EV/Revenue
5.55x
EV/EBIT
73.03x
EV/FCF
104.37x
Earnings Yield
-1.14%
FCF Yield
1.09%
Shareholder Yield
0.97%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. HROW currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.340
NI / EBT
×
Interest Burden
-0.547
EBT / EBIT
×
EBIT Margin
0.076
EBIT / Rev
×
Asset Turnover
0.682
Rev / Assets
×
Equity Multiplier
6.458
Assets / Equity
=
ROE
-24.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HROW's ROE of -24.5% is driven by financial leverage (equity multiplier: 6.46x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.34 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$33.00
Median 1Y
$33.97
5th Pctile
$10.37
95th Pctile
$111.94
Ann. Volatility
69.7%
Analyst Target
$73.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mark L. Baum
Chief Executive Officer
$731,120 $— $1,358,490
Andrew R. Boll
Chief Financial Officer and Corporate Secretary
$491,920 $— $849,201
John P. Saharek
President and Chief Executive Officer, ImprimisRx
$463,431 $— $743,467

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,358,490
Avg Employee Cost (SGA/emp): $409,957
Employees: 373

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
373
-2.4% YoY
Revenue / Employee
$730,035
Rev: $272,303,000
Profit / Employee
$-13,777
NI: $-5,139,000
SGA / Employee
$409,957
Avg labor cost proxy
R&D / Employee
$40,354
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 27.4% -34.4% -93.6% -1.1% -1.3% -1.2% -72.5% -94.1% -83.7% -73.1% -49.8% -64.0% -68.6% -68.2% -25.0% -31.0% -14.6% -7.1% -8.4% -24.5% -24.51%
ROA 12.9% -16.2% -23.1% -26.5% -31.4% -29.0% -11.0% -14.3% -12.7% -11.1% -10.4% -13.4% -14.3% -14.2% -5.0% -6.2% -2.9% -1.4% -1.3% -3.8% -3.80%
ROIC 62.9% 26.4% 3.3% 1.6% -3.4% 4.0% 4.0% 2.1% 3.5% 7.3% 0.2% -3.4% -3.8% -4.0% 2.8% 1.4% 4.5% 8.7% 13.3% 9.6% 9.60%
ROCE 42.7% 15.2% 3.8% 2.9% 0.1% 4.2% 1.4% 0.7% 1.2% 2.5% 0.3% -2.8% -3.1% -3.3% 3.0% 1.6% 4.9% 6.8% 10.3% 6.7% 6.74%
Gross Margin 75.6% 73.6% 74.8% 73.0% 72.0% 70.6% 69.7% 68.3% 70.1% 70.6% 68.9% 69.5% 74.4% 75.6% 78.8% 67.5% 74.5% 75.3% 79.3% 61.2% 61.18%
Operating Margin 23.0% -19.9% -8.7% 9.5% 7.2% -0.4% -8.7% 4.6% 7.0% 5.1% -13.4% -20.0% 3.1% 2.7% 19.3% -23.5% 17.9% 20.6% 27.0% -50.0% -49.95%
Net Margin -13.7% -44.5% -36.7% -11.0% -26.8% -28.3% 5.2% -25.4% -12.6% -12.8% -25.2% -39.2% -13.2% -8.6% 10.1% -37.2% 7.8% 1.4% 7.4% -62.4% -62.44%
EBITDA Margin 25.2% -17.5% 2.0% 13.0% 10.6% 2.1% -5.3% 14.0% 16.2% 13.5% -4.8% -11.8% 8.9% 8.7% 26.3% -14.0% 25.1% 16.2% 32.3% -37.3% -37.32%
FCF Margin 14.4% 6.3% -32.3% -32.6% -30.3% -27.8% -1.0% -11.0% -11.2% -27.4% -14.0% -10.3% -13.4% 1.8% -30.5% -17.2% -15.2% -8.2% 15.8% 5.3% 5.32%
OCF Margin 17.2% 9.0% 7.0% 3.6% 2.7% 4.4% 1.9% -8.1% -7.6% -7.5% 2.9% 5.4% 0.1% 2.5% -11.1% 1.0% 1.8% 7.1% 16.1% 5.7% 5.66%
ROE 3Y Avg snapshot only -34.74%
ROE 5Y Avg snapshot only -70.71%
ROA 3Y Avg snapshot only -6.46%
ROIC 3Y Avg snapshot only -38.69%
ROIC Economic snapshot only 7.43%
Cash ROA snapshot only 3.81%
Cash ROIC snapshot only 6.57%
CROIC snapshot only 6.17%
NOPAT Margin snapshot only 8.27%
Pretax Margin snapshot only -4.16%
R&D / Revenue snapshot only 5.72%
SGA / Revenue snapshot only 32.21%
SBC / Revenue snapshot only 4.39%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 33.00 -26.11 -13.18 -8.99 -8.14 -14.63 -30.84 -35.04 -35.62 -34.65 -16.22 -14.98 -22.16 -48.05 -68.72 -43.92 -116.01 -375.50 -350.51 -87.75 -82.122
P/S Ratio 3.97 3.68 3.28 2.35 2.36 3.73 4.90 6.92 5.65 4.31 3.04 3.38 4.83 9.49 6.02 4.48 5.21 7.49 6.61 4.89 4.578
P/B Ratio 9.14 9.07 21.03 16.45 17.61 29.25 15.74 23.23 21.02 17.84 5.63 6.67 10.58 22.81 17.25 13.68 17.04 26.89 34.35 25.03 42.801
P/FCF 27.62 58.85 -10.14 -7.19 -7.78 -13.42 -479.41 -62.97 -50.60 -15.72 -21.71 -32.93 -36.02 529.76 -19.76 -26.02 -34.39 -91.48 41.95 91.85 91.848
P/OCF 23.11 41.04 46.71 65.36 87.91 84.06 254.75 103.12 63.19 6527.03 375.65 455.10 293.93 105.97 41.06 86.34 86.344
EV/EBITDA 10.76 25.99 51.85 46.38 90.71 57.31 93.62 118.18 69.74 39.86 42.16 136.47 267.45 602.28 62.50 58.15 43.97 53.42 39.82 37.36 37.361
EV/Revenue 3.82 3.55 3.65 2.69 2.68 4.04 5.02 7.04 5.75 4.40 3.87 4.16 5.53 10.13 6.93 5.33 6.01 8.22 7.27 5.55 5.553
EV/EBIT 11.99 33.35 78.70 83.62 3324.29 96.83 231.74 633.57 349.30 142.46 621.09 -78.75 -104.53 -199.82 152.39 237.80 93.39 100.78 63.32 73.03 73.028
EV/FCF 26.60 56.65 -11.30 -8.24 -8.85 -14.53 -490.85 -63.99 -51.50 -16.05 -27.62 -40.49 -41.24 565.31 -22.74 -30.98 -39.65 -100.35 46.12 104.37 104.375
Earnings Yield 3.0% -3.8% -7.6% -11.1% -12.3% -6.8% -3.2% -2.9% -2.8% -2.9% -6.2% -6.7% -4.5% -2.1% -1.5% -2.3% -0.9% -0.3% -0.3% -1.1% -1.14%
FCF Yield 3.6% 1.7% -9.9% -13.9% -12.8% -7.5% -0.2% -1.6% -2.0% -6.4% -4.6% -3.0% -2.8% 0.2% -5.1% -3.8% -2.9% -1.1% 2.4% 1.1% 1.09%
PEG Ratio snapshot only 0.359
EV/OCF snapshot only 98.121
EV/Gross Profit snapshot only 7.493
Acquirers Multiple snapshot only 53.058
Shareholder Yield snapshot only 0.97%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.79 3.79 6.24 6.24 6.24 6.24 6.35 6.35 6.35 6.35 2.82 2.82 2.82 2.82 2.08 2.08 2.08 2.08 2.20 2.20 2.199
Quick Ratio 3.43 3.43 5.81 5.81 5.81 5.81 6.00 6.00 6.00 6.00 2.60 2.60 2.60 2.60 1.96 1.96 1.96 1.96 2.06 2.06 2.058
Debt/Equity 0.87 0.87 6.91 6.91 6.91 6.91 4.07 4.07 4.07 4.07 2.71 2.71 2.71 2.71 3.29 3.29 3.29 3.29 4.80 4.80 4.804
Net Debt/Equity -0.34 -0.34 2.42 2.42 2.42 2.42 0.38 0.38 0.38 0.38 1.53 1.53 1.53 1.53 2.61 2.61 2.61 2.61 3.41 3.41 3.414
Debt/Assets 0.41 0.41 0.79 0.79 0.79 0.79 0.71 0.71 0.71 0.71 0.61 0.61 0.61 0.61 0.59 0.59 0.59 0.59 0.63 0.63 0.631
Debt/EBITDA 1.06 2.58 15.27 16.98 31.28 12.50 23.63 20.36 13.26 8.90 15.94 45.06 59.81 66.98 10.34 11.73 7.35 5.95 5.07 6.31 6.310
Net Debt/EBITDA -0.41 -1.01 5.35 5.94 10.95 4.38 2.18 1.88 1.23 0.82 9.02 25.48 33.83 37.88 8.21 9.31 5.84 4.72 3.60 4.48 4.484
Interest Coverage 6.66 1.70 0.62 0.38 0.01 0.50 0.26 0.10 0.12 0.20 0.04 -0.33 -0.37 -0.40 0.40 0.20 0.59 0.80 1.29 0.88 0.883
Equity Multiplier 2.11 2.11 8.71 8.71 8.71 8.71 5.70 5.70 5.70 5.70 4.43 4.43 4.43 4.43 5.58 5.58 5.58 5.58 7.62 7.62 7.617
Cash Ratio snapshot only 0.757
Debt Service Coverage snapshot only 1.726
Cash to Debt snapshot only 0.289
FCF to Debt snapshot only 0.057
Defensive Interval snapshot only 392.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 1.07 1.15 0.93 1.02 1.08 1.14 0.69 0.72 0.80 0.89 0.56 0.59 0.66 0.72 0.57 0.61 0.65 0.71 0.69 0.68 0.682
Inventory Turnover 4.36 4.70 4.45 4.99 5.51 5.94 4.72 5.15 5.79 6.41 4.55 4.82 5.11 5.33 4.57 5.03 5.37 5.90 5.61 5.74 5.743
Receivables Turnover 26.79 28.64 20.32 22.20 23.65 24.80 16.53 17.27 19.17 21.30 6.13 6.52 7.25 7.96 2.62 2.79 2.98 3.28 2.40 2.36 2.364
Payables Turnover 2.86 3.09 4.13 4.63 5.11 5.51 4.37 4.77 5.37 5.94 2.85 3.01 3.19 3.33 1.64 1.80 1.92 2.11 1.83 1.88 1.877
DSO 14 13 18 16 15 15 22 21 19 17 60 56 50 46 140 131 122 111 152 154 154.4 days
DIO 84 78 82 73 66 61 77 71 63 57 80 76 71 68 80 73 68 62 65 64 63.6 days
DPO 128 118 88 79 71 66 84 77 68 61 128 121 114 110 223 203 190 173 199 194 194.4 days
Cash Conversion Cycle -30 -28 12 11 10 10 16 15 14 13 11 10 7 5 -4 1 1 1 18 23 23.5 days
Fixed Asset Turnover snapshot only 24.330
Operating Cycle snapshot only 217.9 days
Cash Velocity snapshot only 3.684
Capital Intensity snapshot only 1.487
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 38.3% 42.7% 48.3% 50.8% 34.8% 32.3% 22.2% 17.0% 21.8% 29.1% 47.0% 49.8% 50.1% 48.1% 53.3% 53.5% 47.7% 47.8% 36.4% 26.2% 26.22%
Net Income 1.3% -4.1% -4.4% -3.1% -4.2% -1.4% 21.8% 11.5% 33.3% 37.0% -73.3% -71.3% -1.1% -1.4% 28.4% 30.8% 69.5% 85.1% 70.6% 31.0% 31.04%
EPS 1.3% -4.1% -4.0% -3.1% -4.2% -1.4% 27.0% 20.4% 40.2% 49.7% -44.2% -46.3% -76.4% -1.3% 29.3% 31.4% 72.1% 86.3% 71.4% 33.6% 33.65%
FCF 3.8% 6.8% -10.3% -15.9% -3.8% -6.9% 96.1% 60.6% 55.1% -27.4% -19.1% -40.0% -80.2% 1.1% -2.3% -1.6% -67.0% -7.8% 1.7% 1.4% 1.39%
EBITDA 3.0% 2.1% -56.7% -70.0% -88.8% -31.7% -6.9% 20.0% 2.4% 1.0% 1.5% -23.3% -62.4% -77.4% 85.2% 3.6% 8.8% 12.5% 1.2% 1.0% 1.05%
Op. Income 2.5% 5.6% 3.2% -79.7% -1.1% -67.6% 18.9% 28.8% 2.0% 81.7% -77.5% -8.5% -6.0% -3.5% 19.5% 1.6% 2.7% 4.1% 3.4% 5.2% 5.22%
OCF Growth snapshot only 6.26%
Asset Growth snapshot only 2.70%
Equity Growth snapshot only -24.70%
Debt Growth snapshot only 10.12%
Shares Change snapshot only 3.92%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 23.7% 21.5% 20.5% 20.9% 20.7% 21.0% 20.1% 22.2% 31.4% 34.5% 38.6% 38.2% 35.1% 36.2% 40.2% 39.1% 39.2% 41.4% 45.4% 42.6% 42.64%
Revenue 5Y 32.2% 30.5% 29.4% 29.6% 29.0% 28.5% 27.0% 25.7% 25.4% 25.1% 25.8% 25.4% 26.3% 27.6% 31.3% 33.2% 38.2% 39.8% 41.0% 38.6% 38.62%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y -25.2% -37.3% 23.7% 12.1% 0.4% -34.9% -47.7% -32.2% 63.1% 62.0% 1.3% 83.4% 1.2% 93.5% 93.50%
EBITDA 5Y -17.4% -20.6% 54.5% 33.9% 33.4% 21.1% 21.12%
Gross Profit 3Y 37.5% 32.4% 29.7% 27.3% 26.5% 25.2% 22.5% 23.8% 32.5% 34.4% 38.1% 36.7% 32.9% 35.1% 40.5% 39.3% 40.0% 42.7% 47.9% 45.3% 45.31%
Gross Profit 5Y 42.7% 41.0% 39.9% 40.5% 39.9% 39.6% 36.6% 33.5% 31.8% 30.0% 29.5% 27.7% 29.2% 30.3% 34.3% 35.9% 40.7% 41.6% 42.8% 39.4% 39.35%
Op. Income 3Y 3.8% 76.2% 78.2% 1.4% 1.7% 2.0% 2.01%
Op. Income 5Y 1.5% 48.2% 48.22%
FCF 3Y -10.2%
FCF 5Y 52.5% 52.48%
OCF 3Y 1.4% 94.8% 1.5% 21.5% 40.8% -78.0% -10.7% -9.7% 21.3% 65.1% 2.0%
OCF 5Y 41.1% 1.1% 2.2% 73.7% 41.7% 41.74%
Assets 3Y 33.9% 33.9% 25.7% 25.7% 25.7% 25.7% 38.6% 38.6% 38.6% 38.6% 75.7% 75.7% 75.7% 75.7% 58.2% 58.2% 58.2% 58.2% 36.4% 36.4% 36.41%
Assets 5Y 32.4% 32.4% 29.3% 29.3% 29.3% 29.3% 45.8% 45.8% 45.8% 45.8% 44.5% 44.5% 44.5% 44.5% 45.8% 45.8% 45.8% 45.8% 47.4% 47.4% 47.37%
Equity 3Y 1.2% 1.2% -23.0% -23.0% -23.0% -23.0% -0.1% -0.1% -0.1% -0.1% 37.3% 37.3% 37.3% 37.3% 83.4% 83.4% 83.4% 83.4% 23.9% 23.9% 23.87%
Book Value 3Y 1.1% 1.0% -26.1% -23.6% -25.0% -24.7% -4.3% -5.3% -5.4% -7.7% 23.5% 26.1% 24.8% 25.3% 67.9% 67.4% 63.1% 63.1% 15.0% 15.6% 15.64%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.94 0.93 0.92 0.91 0.91 0.91 0.93 0.94 0.94 0.91 0.85 0.85 0.86 0.86 0.83 0.84 0.89 0.90 0.92 0.93 0.932
Earnings Stability 0.17 0.22 0.00 0.00 0.02 0.07 0.25 0.16 0.18 0.45 0.91 0.52 0.55 0.86 0.70 0.17 0.05 0.13 0.01 0.29 0.291
Margin Stability 0.84 0.85 0.85 0.85 0.84 0.84 0.85 0.87 0.88 0.90 0.92 0.94 0.94 0.95 0.95 0.96 0.96 0.97 0.96 0.97 0.969
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.50 0.50 0.20 0.20 0.50 0.91 0.50 0.50 0.85 0.50 0.50 0.50 0.50 0.89 0.88 0.50 0.50 0.50 0.88 0.876
Earnings Smoothness
ROE Trend 0.18 -0.63 -1.54 -1.58 -1.91 -1.79 0.35 0.07 0.35 0.66 0.71 0.80 0.90 0.78 0.18 0.24 0.39 0.42 0.20 0.09 0.093
Gross Margin Trend 0.09 0.07 0.06 0.04 0.02 0.00 -0.01 -0.03 -0.04 -0.04 -0.04 -0.02 -0.00 0.01 0.05 0.05 0.04 0.03 0.03 0.02 0.020
FCF Margin Trend 0.21 0.09 -0.29 -0.34 -0.34 -0.30 0.17 0.04 -0.03 -0.17 0.03 0.12 0.07 0.29 -0.23 -0.07 -0.03 0.05 0.38 0.19 0.191
Sustainable Growth Rate 27.0%
Internal Growth Rate 14.5%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.43 -0.64 -0.28 -0.14 -0.09 -0.17 -0.12 0.41 0.48 0.60 -0.16 -0.24 -0.00 -0.13 1.27 -0.10 -0.39 -3.54 -8.54 -1.02 -1.016
FCF/OCF 0.84 0.70 -4.61 -9.10 -11.29 -6.26 -0.53 1.36 1.48 3.66 -4.75 -1.92 -181.19 0.71 2.74 -17.49 -8.55 -1.16 0.98 0.94 0.940
FCF/Net Income snapshot only -0.955
OCF/EBITDA snapshot only 0.381
CapEx/Revenue 2.8% 2.7% 39.3% 36.2% 33.0% 32.2% 2.9% 2.9% 3.6% 19.9% 17.0% 15.6% 13.5% 0.7% 19.3% 18.2% 16.9% 15.3% 0.3% 0.3% 0.34%
CapEx/Depreciation snapshot only 0.047
Accruals Ratio -0.06 -0.27 -0.30 -0.30 -0.34 -0.34 -0.12 -0.08 -0.07 -0.04 -0.12 -0.17 -0.14 -0.16 0.01 -0.07 -0.04 -0.06 -0.12 -0.08 -0.077
Sloan Accruals snapshot only -0.006
Cash Flow Adequacy snapshot only 16.689
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 1.7%
FCF Payout Ratio 1.4% 3.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 44.2%
Div. Increase Streak 0 0 0 0
Chowder Number
Buyback Yield 1.3% 1.3% 1.3% 2.1% 0.4% 0.3% 0.2% 0.1% 0.1% 0.1% 0.2% 0.2% 0.2% 0.1% 0.2% 0.1% 1.2% 0.7% 0.7% 1.0% 0.97%
Net Buyback Yield 1.3% 1.3% 1.3% 2.1% 0.4% 0.3% -5.2% -3.5% -3.9% -4.6% 0.2% 0.2% 0.1% 0.1% 0.2% 0.1% 1.2% 0.7% 0.7% 0.9% 0.94%
Total Shareholder Return 1.3% 1.3% 1.4% 2.2% 0.4% 0.3% -5.2% -3.5% -3.9% -4.6% 0.2% 0.2% 0.1% 0.1% 0.2% 0.1% 1.2% 0.7% 0.7% 0.9% 0.94%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.01 1.01 1.01 1.01 1.01 0.99 0.98 1.10 1.03 1.03 1.05 1.00 1.01 1.01 0.95 0.91 3.76 1.34 1.340
Interest Burden (EBT/EBIT) 0.38 -1.33 -5.31 -8.06 -356.62 -6.06 -7.30 -18.00 -9.79 -3.68 -29.24 4.14 3.92 3.88 -1.91 -4.51 -0.73 -0.27 -0.04 -0.55 -0.547
EBIT Margin 0.32 0.11 0.05 0.03 0.00 0.04 0.02 0.01 0.02 0.03 0.01 -0.05 -0.05 -0.05 0.05 0.02 0.06 0.08 0.11 0.08 0.076
Asset Turnover 1.07 1.15 0.93 1.02 1.08 1.14 0.69 0.72 0.80 0.89 0.56 0.59 0.66 0.72 0.57 0.61 0.65 0.71 0.69 0.68 0.682
Equity Multiplier 2.12 2.12 4.05 4.05 4.05 4.05 6.58 6.58 6.58 6.58 4.79 4.79 4.79 4.79 5.00 5.00 5.00 5.00 6.46 6.46 6.458
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.28 $-0.35 $-0.66 $-0.76 $-0.89 $-0.82 $-0.48 $-0.60 $-0.53 $-0.41 $-0.69 $-0.88 $-0.94 $-0.94 $-0.49 $-0.61 $-0.26 $-0.13 $-0.14 $-0.40 $-0.40
Book Value/Share $1.02 $1.00 $0.41 $0.41 $0.41 $0.41 $0.94 $0.91 $0.91 $0.81 $1.99 $1.98 $1.98 $1.97 $1.95 $1.94 $1.79 $1.79 $1.43 $1.41 $0.76
Tangible Book/Share $0.91 $0.90 $-0.22 $-0.23 $-0.23 $-0.23 $0.05 $0.05 $0.05 $0.04 $-2.54 $-2.53 $-2.52 $-2.52 $-3.28 $-3.28 $-3.02 $-3.02 $-3.35 $-3.31 $-3.31
Revenue/Share $2.34 $2.47 $2.64 $2.91 $3.09 $3.23 $3.01 $3.06 $3.37 $3.33 $3.68 $3.91 $4.33 $4.74 $5.57 $5.94 $5.86 $6.43 $7.41 $7.22 $7.22
FCF/Share $0.34 $0.15 $-0.85 $-0.95 $-0.94 $-0.90 $-0.03 $-0.34 $-0.38 $-0.91 $-0.52 $-0.40 $-0.58 $0.08 $-1.70 $-1.02 $-0.89 $-0.53 $1.17 $0.38 $0.38
OCF/Share $0.40 $0.22 $0.18 $0.10 $0.08 $0.14 $0.06 $-0.25 $-0.26 $-0.25 $0.11 $0.21 $0.00 $0.12 $-0.62 $0.06 $0.10 $0.45 $1.19 $0.41 $0.41
Cash/Share $1.22 $1.21 $1.84 $1.86 $1.86 $1.85 $3.46 $3.36 $3.34 $2.97 $2.34 $2.33 $2.32 $2.32 $1.32 $1.32 $1.22 $1.22 $1.98 $1.96 $2.54
EBITDA/Share $0.83 $0.34 $0.19 $0.17 $0.09 $0.23 $0.16 $0.18 $0.28 $0.37 $0.34 $0.12 $0.09 $0.08 $0.62 $0.54 $0.80 $0.99 $1.35 $1.07 $1.07
Debt/Share $0.88 $0.87 $2.84 $2.86 $2.86 $2.85 $3.81 $3.71 $3.68 $3.28 $5.39 $5.37 $5.35 $5.34 $6.39 $6.39 $5.89 $5.89 $6.85 $6.77 $6.77
Net Debt/Share $-0.34 $-0.34 $0.99 $1.00 $1.00 $1.00 $0.35 $0.34 $0.34 $0.30 $3.05 $3.04 $3.02 $3.02 $5.07 $5.07 $4.67 $4.67 $4.87 $4.81 $4.81
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.907
Altman Z-Prime snapshot only 4.930
Piotroski F-Score 7 4 6 6 4 4 5 4 4 5 3 5 5 4 4 5 6 5 7 6 6
Beneish M-Score -2.29 -3.45 -1.98 -2.13 -2.28 -2.27 -2.57 -2.46 -2.38 -2.29 0.74 1.19 0.99 0.97 -1.02 -1.16 -1.01 -1.20 -3.05 -2.84 -2.843
Ohlson O-Score snapshot only -4.318
Net-Net WC snapshot only $-3.64
EVA snapshot only $-937070.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 83.66 70.35 26.08 26.27 26.29 39.03 36.66 43.89 43.83 39.78 24.41 27.28 33.66 49.19 36.92 32.15 37.64 48.26 53.15 38.93 38.930
Credit Grade snapshot only 13
Credit Trend snapshot only 6.780
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 27
Sector Credit Rank snapshot only 31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms